Business Wire

SES

28.4.2021 08:52:11 CEST | Business Wire | Press release

Share
SES’s Next-Gen NGSO System Readies for Launch with 8 Initial O3b mPOWER Satellite Ground Stations

SES announced today that it has signed agreements with key infrastructure service providers around the world to build its eight initial O3b mPOWER satellite ground stations. Construction has already started on these advanced technology satellite ground stations, which will become operational in the second half of this year. The eight sites will provide telemetry, tracking and control capabilities to enable SES’s management of the constellation. They will also be leveraged to raise the satellites into the right orbit after the scheduled launches.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210427006193/en/

As previously announced, two of the satellite ground stations are located at Dubbo, NSW, Australia (operated by Pivotel) and Thermopylae, Greece (operated by OTE) . Other locations include Merredin, Perth, Australia; Phoenix, Arizona, US; Chile; the United Arab Emirates; Senegal as well as SES’s own satellite ground station in Hawaii. Four out of the eight sites will be co-located and operated with Microsoft’s Azure data centres ; the one-hop connectivity to the cloud from remote sites will provide O3b mPOWER customers the ability to optimise business operations with significant flexibility and agility.

O3b mPOWER is SES’s next-generation Medium Earth Orbit (MEO) system. Building on the success of O3b, each of the 11 high-throughput, low-latency O3b mPOWER satellites will deliver high-speed connectivity services from tens of megabits to multiple gigabits per second, providing fibre-like connectivity to customers globally.

The O3b mPOWER satellite ground stations have many technically advanced features compared to the existing O3b satellite ground station. They include a new generation of fast-install 5.5-metre carbon fibre antennas which can be installed without the need for expensive and time-consuming photogrammetry. In addition, they will utilise energy-efficient solid-state power amplifiers, and a low electrical load for the antenna control unit (ACU).

The satellite ground stations will use SES’s gateway management system for automated operations and handovers, which will be tightly integrated with SES’s unique resource management capability, Adaptive Resource Control (ARC) and other SES software sub-systems. With this configuration, SES will dynamically manage and optimise space and ground resources to meet the changing needs of its customers. These combined technology advances result in improved efficiency and lower total cost of ownership.

The first three O3b mPOWER satellites are scheduled for launch in the third quarter of this year, with the next three in the first quarter of 2022. After orbit raising, O3b mPOWER will start delivering services in the third quarter of 2022.

Stewart Sanders, Executive Vice President of Technology and O3b mPOWER programme manager at SES, said, “We are thrilled to have chosen these eight locations and construction is underway. We are also deep in discussions with several telco players and operators who are keen to have their own O3b mPOWER satellite ground station. This is particularly exciting, as it means that SES’s provision of a core network of command, control and data gateways will be augmented with a number of customer satellite ground stations; satellite ground stations provisioned according to our customer needs, with regards to location, size and infrastructure requirements. We expect a number of these customer satellite ground stations to include virtualised installations of the cloud at the edge of the deployed networks, thus improving the end-user experience.”

Follow us on:

Read our Blogs >

Visit the Media Gallery >

About SES

SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 8,200 channels and has an unparalleled reach of 361 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com .

Link:

ClickThru

Social Media:

https://www.facebook.com/SES.Satellites/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye